Tremblay, Melanie

Publishing since 1988 (Dinosaur)

Has published 106 publications in 23 years

Number of publications published per year by Tremblay, Melanie. (Source : PubMed)

Distribution of publications types for Tremblay, Melanie. (Source : PubMed)
(a publication can be of different types, so total may exceed publications count)

Recent publications

•  Dubuc G, Tremblay M, Paré G, Jacques H, Hamelin J, Benjannet S, Boulet L, Genest J, Bernier L, Seidah NG, Davignon J. A new method for measurement of total plasma PCSK9: clinical applications.  J. Lipid Res.  2010;51;1  
•  Tremblay M, Payette Y, Montreuil A. Use and reimbursement costs of smoking cessation medication under the Quebec public drug insurance plan.  Can J Public Health  2009;100;6  
•  Gagnon A, Smith KR, Tremblay M, Vézina H, Paré PP, Desjardins B. Is there a trade-off between fertility and longevity? A comparative study of women from three large historical databases accounting for mortality selection.  Am. J. Hum. Biol.  2009;21;4  
•  Curran V, Casimiro L, Banfield V, Hall P, Lackie K, Simmons B, Tremblay M, Wagner SJ, Oandasan I. Research for interprofessional competency-based evaluation (RICE).  J Interprof Care  2009;23;3  
•  Robert A, Toupance B, Tremblay M, Heyer E. Impact of inbreeding on fertility in a pre-industrial population.  Eur. J. Hum. Genet.  2009;17;5  
•  Tremblay M. Commentary: Risks of doing as the Romans do.  BMJ  2009;338  
•  Adamo KB, Prince SA, Tricco AC, Connor-Gorber S, Tremblay M. A comparison of indirect versus direct measures for assessing physical activity in the pediatric population: a systematic review.  Int J Pediatr Obes  2009;4;1  
•  Rafei M, Hsieh J, Fortier S, Li M, Yuan S, Birman E, Forner K, Boivin MN, Doody K, Tremblay M, Annabi B, Galipeau J. Mesenchymal stromal cell-derived CCL2 suppresses plasma cell immunoglobulin production via STAT3 inactivation and PAX5 induction.  Blood  2008;112;13  
•  Zaid A, Roubtsova A, Essalmani R, Marcinkiewicz J, Chamberland A, Hamelin J, Tremblay M, Jacques H, Jin W, Davignon J, Seidah NG, Prat A. Proprotein convertase subtilisin/kexin type 9 (PCSK9): hepatocyte-specific low-density lipoprotein receptor degradation and critical role in mouse liver regeneration.  Hepatology  2008;48;2  
•  Bisson N, Tremblay M, Robinson F, Kaplan DR, Trusko SP, Moss T. Mice lacking both mixed-lineage kinase genes Mlk1 and Mlk2 retain a wild type phenotype.  Cell Cycle  2008;7;7  

[ See timeline ] [ See all publications ]